3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Lung Neoplasms
4
Colorectal Neoplasms
4
Stomach Neoplasms
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Neoplasms
2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
Wilms Tumor
1
Venous Thromboembolism
1
Uveal Melanoma
1
Untreated Human Epidermal Growth Factor Receptor-2(HER2)Positive Early Breast Cancer
1
Smoking Cessation
1
Recurrence
1
Rectal Neoplasms
1
Pulmonary Disease, Chronic Obstructive
1
Neoplastic Cells, Circulating
1
Motor Activity
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Leukemia, Myeloid, Acute
1
Leukemia
1
Hodgkin Disease
1
Hepatic Veno-Occlusive Disease
1
HPV Positive Oropharyngeal Squamous Cell Carcinoma
1
Fibrosis
1
Esophageal Neoplasms
1
Colorectal Neoplasms, Hereditary Nonpolyposis
1
Colonic Neoplasms
1
Cardiovascular Diseases
1
Carcinoma, Hepatocellular
1
Breast Neoplasms
1
Interventions
Blood Specimen Collection
9
Surgical Procedures, Operative
3
Liquid Biopsy
3
Spinal Puncture
2
Laparoscopy
2
Anesthesia, General
2
Sevoflurane
1
Propofol
1
Positron Emission Tomography Computed Tomography
1
Oxaliplatin
1
Needles
1
Lymph Node Excision
1
Leucovorin
1
Hematologic Tests
1
Drug Therapy
1
Diagnostic Imaging
1
Conversion to Open Surgery
1
Biopsy, Fine-Needle
1
Anterior Temporal Lobectomy
1
Anesthesia, Spinal
1
Analgesia, Epidural
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Neoplastic Cells, Circulating
×
Hematologic Tests
×
Clear all
NCT02610764
2017-04-13
ESO-CTC
University Hospital Freiburg
Phase NA
Completed
19 enrolled